{
    "eid": "2-s2.0-85043353177",
    "title": "Anti-neutrophil cytoplasmic antibodies and their clinical significance",
    "cover-date": "2018-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Rheumatology",
            "@code": "2745",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "ANCA",
        "ANCA staining pattern",
        "ANCA-associated vasculitis"
    ],
    "authors": [
        "Supaporn Suwanchote",
        "Muanpetch Rachayon",
        "Pongsawat Rodsaward",
        "Jongkonnee Wongpiyabovorn",
        "Tawatchai Deekajorndech",
        "Helen L. Wright",
        "Steven W. Edwards",
        "Michael W. Beresford",
        "Pawinee Rerknimitr",
        "Direkrit Chiewchengchol"
    ],
    "citedby-count": 32,
    "ref-count": 99,
    "ref-list": [
        "Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?",
        "Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis",
        "ANCA-associated vasculitis with renal involvement",
        "2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides",
        "International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA)",
        "A historical essay on detection of anti-neutrophil cytoplasmic antibodies",
        "ANCA testing: the current stage and perspectives",
        "Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions",
        "Clinical significance of a positive antineutrophil cytoplasmic antibody (ANCA) test",
        "Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness",
        "Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener\u2019s granulomatosis: first results from a multicentre study",
        "Fifty years of antineutrophil cytoplasmic antibodies (ANCA) testing: Do we need to revise the international consensus statement on testing and reporting on ANCA?",
        "Comparative analysis of different commercial ELISA systems for the detection of anti-neutrophil cytoplasm antibodies in ANCA-associated vasculitides",
        "High-sensitivity detection of autoantibodies against proteinase-3 by a novel third-generation enzyme-linked immunosorbent assay",
        "Performance of two strategies for urgent ANCA and anti-GBM analysis in vasculitis",
        "Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis",
        "Clinical relevance of anti-PR3 capture ELISA in diagnosing Wegener\u2019s granulomatosis",
        "ANCA-negative Wegener\u2019s granulomatosis with multiple lower cranial nerve palsies",
        "Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules",
        "Novel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodies",
        "ANCA-associated vasculitis\u2014clinical utility of using ANCA specificity to classify patients",
        "Neutrophil anti-neutrophil cytoplasmic autoantibody proteins: bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of inflammatory bowel and other diseases",
        "ANCA in the diagnosis of neutrophil-mediated inflammation",
        "Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): specificity and clinical associations",
        "ANCA-associated vasculitis: pathogenesis, models, and preclinical testing",
        "Pathogenesis and treatment of ANCA-associated vasculitis\u2014a role for complement",
        "Pathogenesis of ANCA-associated vasculitis: an update",
        "Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms",
        "Implication of B lymphocytes in the pathogenesis of ANCA-associated vasculitides",
        "Overview of the pathogenesis of ANCA-associated vasculitis",
        "Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease",
        "Immune regulatory mechanisms in ANCA-associated vasculitides",
        "ANCA-associated vasculitis pathogenesis: a commentary",
        "Experimental models of vasculitis and glomerulonephritis induced by antineutrophil cytoplasmic autoantibodies",
        "Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis",
        "Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs",
        "Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis",
        "Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement",
        "Usefulness of antineutrophil cytoplasmic autoantibodies in diagnosing and managing systemic vasculitis",
        "Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease",
        "Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody",
        "Key advances in the clinical approach to ANCA-associated vasculitis",
        "Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis",
        "Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals",
        "Predictors of poor outcome in ANCA-associated vasculitis (AAV)",
        "Diagnosing ANCA-associated vasculitis in ANCA positive patients: a retrospective analysis on the role of clinical symptoms and the ANCA titre",
        "ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease",
        "Santos J (2016) ANCA-positive vasculitis: clinical implications of ANCA types and titers",
        "Classification of ANCA-associated vasculitis",
        "Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis",
        "Cutaneous manifestations of ANCA-associated small vessels Vasculitis",
        "Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment",
        "The antineutrophil cytoplasmic antibody-associated vasculitides",
        "Clinic manifestations in granulomatosis with polyangiitis",
        "The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA)",
        "The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis",
        "EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis",
        "Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive and ANCA-negative patients with granulomatosis with polyangiitis (Wegener\u2019s): distinct patient subsets",
        "Prospective long-term follow-up of patients with localised Wegener\u2019s granulomatosis: does it occur as persistent disease stage?",
        "The diagnosis and classification of microscopic polyangiitis",
        "Antineutrophil cytoplasmic antibodies",
        "ANCA-associated vasculitis with renal involvement",
        "Cutaneous manifestations in patients with microscopic polyangiitis: two case reports and a minireview",
        "Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis",
        "Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force",
        "Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis",
        "A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis",
        "The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)",
        "Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome",
        "Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome",
        "ANCA-positive and ANCA-negative phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA): outcome and long-term follow-up of 50 patients from a single Polish center",
        "Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort",
        "A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients",
        "Editorial: can an increase in antineutrophil cytoplasmic autoantibody titer predict relapses in Antineutrophil cytoplasmic antibody-associated vasculitis?",
        "ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease",
        "Prospective monitoring of in vitro produced PR3-ANCA does not improve relapse prediction in granulomatosis with polyangiitis",
        "ASCA, ANCA, ALCA and many more: are they useful in the diagnosis of inflammatory bowel disease?",
        "Contribution of immunofluorescence to identification and characterization of antineutrophil cytoplasmic antibodies in inflammatory bowel disease",
        "Biomarkers in management of inflammatory bowel disease",
        "Diagnosis and classification of ulcerative colitis",
        "Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value",
        "Position paper: revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis",
        "PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease",
        "Clinical significance of autoantibodies in autoimmune hepatitis",
        "Diagnosis and classification of primary sclerosing cholangitis",
        "Autoantibodies in autoimmune liver diseases",
        "Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis",
        "Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis",
        "Drug-induced glomerular disease: immune-mediated injury",
        "What do antineutrophil cytoplasmic antibodies (ANCA) tell us?",
        "Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves\u2019 patients treated with propylthiouracil",
        "Hydralazine-induced pauci-immune glomerulonephritis: intriguing case series with misleading diagnoses",
        "Extensive levamisole-induced vasculitis",
        "Drug-induced vasculitis: new insights and a changing lineup of suspects",
        "Cocaine-induced vasculitis: clinical and immunological spectrum",
        "Longitudinal development of mucoid pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis",
        "Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis",
        "BPI-ANCA provides additional clinical information to anti-pseudomonas serology: Results from a cohort of 117 Swedish cystic fibrosis patients",
        "Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Liverpool",
            "@id": "60020661",
            "affilname": "University of Liverpool",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020661",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Liverpool",
            "@id": "60024857",
            "affilname": "Alder Hey Children's NHS Foundation Trust",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024857",
            "affiliation-country": "United Kingdom"
        }
    ],
    "funding": [
        "Department of Microbiology",
        "Skin and Allergy Research Unit",
        "Department of Medicine, Faculty of Medicine, Chulalongkorn University"
    ]
}